🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,136 results for “First Tracks Biotherapeutics” Clear

  1. Letrozole

    First Tracks Biotherapeutics

    Polycystic Ovary Syndrome

    phase 3 small molecule completed

    1 trial

  2. Megestrol（Yining）

    First Tracks Biotherapeutics

    Stage III Esophageal Squamous Cell Carcinoma

    phase 3 small molecule completed

    1 trial

  3. Metformin plus pioglitazone

    First Tracks Biotherapeutics

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  4. Methylprednisolone pulse

    First Tracks Biotherapeutics

    Glomerulonephritis, IGA

    phase 3 small molecule terminated

    1 trial

  5. Methylprednisolone sodium succinate

    First Tracks Biotherapeutics

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  6. Mimetic granules of Yiqi-Wenjing prescriptions

    First Tracks Biotherapeutics

    Chemotherapy-induced Peripheral Neuropathy

    phase 3 small molecule active

    1 trial

  7. Mitoxantrone Hydrochloride Liposome

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule active

    1 trial

  8. N-Acetylcysteine

    First Tracks Biotherapeutics

    Thrombotic Microangiopathies

    phase 3 small molecule completed

    1 trial

  9. N-Acetylcysteine (NAC) Treatment

    First Tracks Biotherapeutics

    Thrombotic Microangiopathy

    phase 3 small molecule active

    1 trial

  10. Nedaplatin

    First Tracks Biotherapeutics

    Nasopharyngeal Carcinoma

    phase 3 small molecule completed

    1 trial

  11. Nimotuzumab

    First Tracks Biotherapeutics

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  12. Normal Saline

    First Tracks Biotherapeutics

    Postoperative Sleep Disturbance

    phase 3 small molecule active

    1 trial

  13. Osimertinib

    First Tracks Biotherapeutics

    Non-small Cell Carcinoma

    phase 3 small molecule active

    1 trial

  14. Oxaliplatin

    First Tracks Biotherapeutics

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  15. Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU

    First Tracks Biotherapeutics

    Hepatocellular Carcinoma

    phase 3 small molecule active

    1 trial

  16. Paclitaxel

    First Tracks Biotherapeutics

    Esophageal Cancer

    phase 3 small molecule active

    1 trial

  17. Paclitaxel or docetaxel + Cisplatin or carboplatin

    First Tracks Biotherapeutics

    Uterine Cervical Neoplasms

    phase 3 small molecule active

    1 trial

  18. Paclitaxel, Cisplatin Plus 5-FU (TCF)

    First Tracks Biotherapeutics

    Esophageal Cancer Stage IIB

    phase 3 other active

    1 trial

  19. Pembrolizumab

    First Tracks Biotherapeutics

    Esophageal Squamous Cell Carcinoma

    phase 3 mab active

    1 trial

  20. Preoperative hepatic and regional arterial chemotherapy using oxaliplatin, MMC and FUDR

    First Tracks Biotherapeutics

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  21. Realgar-Indigo naturalis formula

    First Tracks Biotherapeutics

    Acute Promyelocytic Leukemia

    phase 3 small molecule active

    1 trial

  22. Recombinant Human Albumin Injection

    First Tracks Biotherapeutics

    Hepatic Ascites

    phase 3 mab completed

    2 trials

  23. Recombinant Human Thrombopoietin (rhTPO)

    First Tracks Biotherapeutics

    Immune Thrombocytopenia

    phase 3 small molecule completed

    1 trial

  24. Remdesivir

    First Tracks Biotherapeutics

    Covid19

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources